glp 1 asthma GLP-1 receptor agonists tied to reduced acute exacerbations in teens with overweight, obesity GLP-1 Drugs May Cut Asthma

15 Months of Progress After 15 months of consistent treatment with Tirzepatide at a dose of 7.5 mg/week, JHs results were nothing short of inspiring: Follow-Up Bioimpedance Spectroscopy Measurements: Weight: 162 lbs (a 78-lb loss) Body Fat Percentage: 32.9% (down 12.8%) BMI: 23.3 (a reduction of 10.1 kg/m) Body Fat Mass: 53.2 lbs (a decrease of 56 lbs) Lean Body Mass: 109 lbs (down 21 lbs) Skeletal Muscle Mass: 59 lbs (loss of only 12 lbsjust 15% of her total weight loss, less than the typical 20%) ECW/TBW: Slight improvement in the right leg to 0.396

People with a history of seizures or epilepsy face the highest risk

Details related to the statistical tests used are reported in each figure legend

Prescription weight loss medications, such as Wegovy, often require prior authorization before theyre covered

Temporary discontinuation may be necessary for more major side effects

Clinical trials show average weight loss ranging from around 15% of body weight with semaglutide to over 20% with newer dual-mechanism medications like tirzepatide